Drugs News and Research

RSS

Social and economic inequality associated with differences in children's brain connections

Growing up in a socioeconomically disadvantaged household may have lasting effects on children's brain development, a large new study suggests.

1 Nov 2022

Researchers unravel how the brain chemical dopamine relates to schizophrenia

Researchers at the Lieber Institute for Brain Development (LIBD) believe they have solved a riddle that has challenged scientists for more than 70 years: how the brain chemical dopamine relates to schizophrenia, the often-devastating brain disorder characterized by delusional thinking, hallucinations and other forms of psychosis.

1 Nov 2022

SARS-CoV-2 can disrupt normal mix of gut bacteria to increase risk for other infections

Infection with the pandemic virus, SARS-CoV-2, can reduce the number of bacterial species in a patient's gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study finds.

1 Nov 2022

The serial interval and incubation period for symptom and rash onset for monkeypox virus infection during the current US outbreak

Researchers estimated the serial interval and incubation period of monkeypox virus (MPXV) infections for the 2022 disease outbreak in the United States (US).

1 Nov 2022

How does the ISG15/ISGylation system modulate Vaccinia virus infection?

Researchers demonstrated how interferon-stimulated gene 15 (ISG15) is involved in the Vaccinia virus (VACV) dissemination.

1 Nov 2022

Researchers take a cue from viruses to make glioblastoma more vulnerable to treatment

In the tough war against glioblastoma, scientists are taking a cue from viruses on how to make the aggressive cancer more vulnerable to treatment.

1 Nov 2022

Cohort study determines how often COVID-19 symptoms recurred

Researchers at University of California San Diego School of Medicine, with colleagues from the ACTIV-2 trial, part of the U.S. government's response to COVID-19, investigated whether symptoms of COVID-19 recurred following a two-day symptom-free period in persons who did not receive any treatment for the disease.

1 Nov 2022

Novel delivery system selectively delivers antibiotics to specific targets

Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.

1 Nov 2022

People who had COVID-19 are more vulnerable to developing neurological symptoms

Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson's disease.

1 Nov 2022

Researchers develop special molecules that stimulate the immune system

Surgery, radiation, and chemotherapy are the three main therapies used to treat cancerous tumors. The doctoral research network 'Magicbullet::Reloaded'is investigating another approach, with 15 doctoral researchers developing special molecules that stimulate the immune system to destroy tumor cells. In a video, network members explain how doctoral researchers gain valuable experience and research opportunities as part of the network.

1 Nov 2022

BCRF renews funding to support the development of novel therapeutics for triple-negative breast cancer

The Breast Cancer Research Foundation (BCRF) has renewed its funding to Elisa Port, MD, and Hanna Irie, MD, PhD, to study new therapeutic approaches that target aggressive triple-negative breast cancer.

31 Oct 2022

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found.

31 Oct 2022

COVID-19 pandemic increased deaths and disease caused by tuberculosis

A new report published by the World Health Organization indicated a decrease in global spending on essential TB services from US$6 billion in 2019 to US$5.4 billion in 2021.

31 Oct 2022

COVID-19-positive donor hearts appear to be safe for transplantation

Donor hearts from people who were COVID-19-positive appeared to be as safe for transplantation as those from people without COVID-19, according to a short-term analysis to be presented at the American Heart Association's Scientific Sessions 2022.

31 Oct 2022

Increasing Awareness Surrounding Ataxia

In this interview, we speak to Dr. Lauren Moore from the National Ataxia Foundation about the condition and the importance of raising awareness for ataxia.

31 Oct 2022

Open enrollment for marketplace health plans is soon. Here’s what you need to know.

It's fall again, meaning shorter days, cooler temperatures, and open enrollment for Affordable Care Act marketplace insurance — sign-ups begin this week for coverage that starts Jan. 1, 2023.

31 Oct 2022

Study finds increased antioxidant activity in citrus honey

Citrus honey has an increased abundance of antioxidants in comparison to other standard types of honey, according to a new study by University of the West of Scotland (UWS).

31 Oct 2022

Updated EULAR recommendations for children with pedAIIRD

People with autoimmune or auto-inflammatory rheumatic diseases have an increased risk of infections. This can be due to the underlying disease itself, or may be caused by treatment with immunomodulating or immunosuppressive drugs.

28 Oct 2022

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

The 10th annual Appel Alzheimer's Disease Research Institute Symposium brought fascinating reports of progress in understanding Alzheimer's and related neurodegenerative diseases.

28 Oct 2022

Faulty gene may explain why some people gain excessive weight despite normal food intake

A faulty gene, rather than a faulty diet, may explain why some people gain excessive weight even when they don't eat more than others, UT Southwestern researchers at the Center for the Genetics of Host Defense have discovered.

28 Oct 2022

Drugs News and Research

Social and economic inequality associated with differences in children's brain connections

Researchers unravel how the brain chemical dopamine relates to schizophrenia

SARS-CoV-2 can disrupt normal mix of gut bacteria to increase risk for other infections

The serial interval and incubation period for symptom and rash onset for monkeypox virus infection during the current US outbreak

How does the ISG15/ISGylation system modulate Vaccinia virus infection?

Researchers take a cue from viruses to make glioblastoma more vulnerable to treatment

Cohort study determines how often COVID-19 symptoms recurred

Novel delivery system selectively delivers antibiotics to specific targets

People who had COVID-19 are more vulnerable to developing neurological symptoms

Researchers develop special molecules that stimulate the immune system

BCRF renews funding to support the development of novel therapeutics for triple-negative breast cancer

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

COVID-19 pandemic increased deaths and disease caused by tuberculosis

COVID-19-positive donor hearts appear to be safe for transplantation

Increasing Awareness Surrounding Ataxia

Open enrollment for marketplace health plans is soon. Here’s what you need to know.

Study finds increased antioxidant activity in citrus honey

Updated EULAR recommendations for children with pedAIIRD

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

Faulty gene may explain why some people gain excessive weight despite normal food intake

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News